Background: Nocardia are organisms that can escape the effects of both immune response and antimicrobial agents, due to their potential capacity to grow intracellularly. In previous studies, we found that experimental oxazolidinones, DA-7157 and DA-7218, are active both in vitro and in vivo.
Objectives: In this study, we compare the ability of linezolid, DA-7157 and DA-7218 to inhibit intracellular growth of Nocardia brasiliensis within the human monocyte cell line THP-1.
Methods And Results: The addition of oxazolidinones to the infected macrophage monolayer at concentrations 0.25x, 1x, 4x and 16x the MIC for N. brasiliensis resulted in an inhibitory effect on bacterial growth as follows DA-7157 > or = DA-7218 > linezolid.
Conclusions: The excellent intracellular antimicrobial activity detected suggests that these compounds could be effective in the treatment of actinomycetoma. However, more studies are needed both in vitro and in vivo, including clinical trials, to confirm this issue.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1093/jac/dkp314 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Tedizolid: A New Oxazolidinone Antibiotic for Skin and Soft Tissue Infections.
Consult Pharm
July 2015
Lloyd L. Gregory School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, Florida, USA.
Objective: To review the chemistry, pharmacology, microbiology, pharmacodynamics, pharmacokinetics, clinical efficacy, tolerability, drug interactions, dosing, and administration of tedizolid phosphate (TDZ).
Data Sources: A search of PubMed using the terms "tedizolid," "torezolid," "TR-701," "TR-700," "DA-7157," and "DA-7218" was performed. The manufacturer's Web site was also reviewed to further identify relevant information.
HPLC method for the simultaneous analysis of fluoroquinolones and oxazolidinones in plasma.
J Chromatogr Sci
July 2015
Departamento de Química Analítica Facultad de Medicina, Universidad Autónoma de Nuevo León, Av. Madero y Dr. E. Aguirre Pequeño S/N Col. Mitras Centro, 64460 Monterrey, Nuevo León, México.
A chromatographic method was implemented and validated for the simultaneous determination of antimicrobials proposed for the treatment of mycetoma: three fluoroquinolones: ciprofloxacin, moxifloxacin and sparfloxacin; two oxazolidinones: DA-7157 (DA2; torezolid) and its prodrug DA-7218 (DA1). Separation of analytes was achieved on an Atlantis dC18 column (150 × 4.6 mm i.
View Article and Find Full Text PDFActinomycetoma and advances in its treatment.
Clin Dermatol
October 2012
Department of Dermatology, Dr. Jose E. Gonzalez University Hospital, Universidad Autonoma de Nuevo Leon, Ave Madero y Ave Gonzalitos s/n, Colonia Mitras Centro, Monterrey, Nuevo Leon, Mexico.
Actinomycetoma is a chronic subcutaneous infection caused by aerobic branching actinomycetes. Its clinical features are firm tumefaction of the affected site and the presence of abscesses, nodules, and sinuses that drain a seropurulent exudate containing filamenting granules. The disease is caused by inoculation of the infectious agent through minor trauma in susceptible individuals.
View Article and Find Full Text PDFActivity of novel oxazolidinones against Nocardia brasiliensis growing within THP-1 macrophages.
J Antimicrob Chemother
November 2009
Servicio de Dermatología, Hospital Universitario José E. González, Monterrey, N.L., México.
Background: Nocardia are organisms that can escape the effects of both immune response and antimicrobial agents, due to their potential capacity to grow intracellularly. In previous studies, we found that experimental oxazolidinones, DA-7157 and DA-7218, are active both in vitro and in vivo.
Objectives: In this study, we compare the ability of linezolid, DA-7157 and DA-7218 to inhibit intracellular growth of Nocardia brasiliensis within the human monocyte cell line THP-1.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!